Timothy P. Gauthier, Pharm.D., BCPS, BCIDP    
Director, ID PGY2 Pharmacy Residency Program 
Manager, Antimicrobial Stewardship Clinical Program
Baptist Health South Florida

Mark Hauser, M.D. 
Moderator 
President Medical Staff Affairs, Clinical Enterprise
Baptist Health South Florida 

Denise Payne, RN, MSN, MBA, CPHQ, CJCP, FACHE
Corporate Director, Quality, Patient Safety & Regulatory Affairs
Baptist Health South Florida

Richard Levine, M.D. 
Infectious Disease Specialist 
Baptist, South Miami and Doctors Hospitals

Timothy P. Gauthier, Pharm.D., BCPS, BCIDP, director and panelist for this educational activity, has indicated that he is a consultant with Pattern Biosciences (formerly Klaris diagnostics), DoseMeRx by Tabula rasa, Pfizer and MeMed. Speaker has indicated that his presentation will include discussion of investigational product use for a drug currently under CDC IRB review. The views and opinions in this presentation are that of the presenter and do not necessarily represent the policy or position of any past, current, or potential future employer. All of the relevant financial relationships listed for this individual have been mitigated.

Denise Payne, RN, MSN, MBA, CPHQ, CJCP, FACHE, panelist for this education activity, has no relevant financial relationship to disclose with ineligible companies*.

Mark Hauser, M.D., moderator for this educational activity, have no relevant financial relationships to disclose with ineligible companies*.

Richard Levine, M.D., conference director and panelist for this educational activity, has no relevant financial relationships to disclose with ineligible companies*.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer